Welsis

WLSS

Medical - Healthcare Information Services · Healthcare

Price

$0.60

-1.89 (-75.90%)

Market Cap

$1.7M

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Welsis Corp. is a small healthcare technology company focused on digital health services. It aims to connect patients with healthcare providers through software platforms and information tools. The company operates in the healthcare information services industry, which helps doctors, clinics, and patients manage health data more efficiently.

Welsis generates revenue through software licensing and service fees tied to its digital health platforms. It is a very small company, with a market cap near zero, meaning it has minimal revenue and limited commercial scale at this time. The company faces significant execution risk — it must prove it can grow its customer base and convert its technology into consistent, recurring revenue before it runs out of resources.

---

*Note: Welsis Corp. (WLSS) has very limited publicly available information. The description above is based on general industry context and available financial signals. Investors should verify current business details directly from company filings before drawing conclusions.*

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+59.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

Research and development spending

Insider Activity

72.7%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$0 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Welsis has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 3y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 2.8M (2022) → 2.8M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial